Latest AIKI reports update at 2024-05-09: 2024-Q12023-Q42023-Q1
AIkido Pharma logo

AIkido Pharma AIKI

$ 3.17 1.93%

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NASDAQ CAPITAL

CEO

Mr. Anthony C. Hayes Esq.

Employees in the company

3

Shares

5.23 M

Market Cap[1]

$ 17.4 M

EBITDA (LTM)

$ -14 M

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Pluristem Therapeutics Pluristem Therapeutics
PSTI
$ 1.03 -1.9 % $ 33.3 M Nasdaq Global Select Market israelIsrael
Avid Bioservices Avid Bioservices
CDMO
$ 6.99 -1.55 % $ 435 M Nasdaq Capital Market usaUSA
Sorrento Therapeutics Sorrento Therapeutics
SRNE
$ 0.27 -29.58 % $ 126 M Nasdaq Global Select Market usaUSA
AnPac Bio-Medical Science Co., Ltd. AnPac Bio-Medical Science Co., Ltd.
ANPC
$ 4.37 -1.58 % $ 28.1 M Nasdaq Global Market chinaChina
ERYTECH Pharma S.A. ERYTECH Pharma S.A.
ERYP
$ 0.78 1.3 % $ 27.7 M Nasdaq Global Select Market franceFrance
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
$ 31.13 2.44 % $ 3.22 B Nasdaq Capital Market,SPB usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
$ 1.47 -5.16 % $ 5.39 M Nasdaq Capital Market usaUSA
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
$ 4.93 1.02 % $ 90.8 M Nasdaq Global Select Market britainBritain
Advaxis Advaxis
ADXS
$ 0.31 -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Heat Biologics, Inc. Heat Biologics, Inc.
HTBX
$ 3.93 -5.76 % $ 99.8 M Nasdaq Capital Market usaUSA
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
$ 6.2 - $ 154 M Nasdaq Capital Market usaUSA
Zymeworks Zymeworks
ZYME
$ 6.42 - $ 404 M NYSE canadaCanada
Akebia Therapeutics Akebia Therapeutics
AKBA
$ 0.9 5.35 % $ 169 M Nasdaq Global Market usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
$ 10.5 - $ 231 M Nasdaq Global Market usaUSA
Amarin Corporation plc Amarin Corporation plc
AMRN
$ 0.71 -2.22 % $ 289 M Nasdaq Global Market irlandaIrlanda
Kadmon Holdings, Inc. Kadmon Holdings, Inc.
KDMN
$ 9.5 - $ 1.7 B Nasdaq Global Select Market usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
$ 2.13 1.91 % $ 220 M Nasdaq Global Market,SPB usaUSA
Exelixis Exelixis
EXEL
$ 22.35 0.38 % $ 7.11 B Nasdaq Global Select Market,SPB usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
$ 2.58 -4.8 % $ 255 M Nasdaq Global Select Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.